Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 105

Results For "LTI"

2564 News Found

Indranil Sen, CFO, Biocon resigned
People | March 16, 2024

Indranil Sen, CFO, Biocon resigned

Sen spent a decade with Biocon and held various key roles,


Merck plans to conduct clinical trials of a novel investigational HPV vaccine for GARDASIL9
Clinical Trials | March 14, 2024

Merck plans to conduct clinical trials of a novel investigational HPV vaccine for GARDASIL9

Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers


Successful use of Zidebactam/Cefepime to treat skull bone infection & pneumonia caused by extreme-drug resistant pseudomonas
Clinical Trials | March 12, 2024

Successful use of Zidebactam/Cefepime to treat skull bone infection & pneumonia caused by extreme-drug resistant pseudomonas

With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained


AbCellera and Biogen collaborate on neurological antibody therapy
News | March 12, 2024

AbCellera and Biogen collaborate on neurological antibody therapy

AbCellera will receive an upfront payment and is eligible to receive additional milestone payments


Solara Active Pharma elevates Arun Kumar Baskaran to the post of CFO
People | March 09, 2024

Solara Active Pharma elevates Arun Kumar Baskaran to the post of CFO

Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function


Dishman Carbogen Amcis updates on USFDA inspection at its Bavla facility
Drug Approval | March 09, 2024

Dishman Carbogen Amcis updates on USFDA inspection at its Bavla facility

The inspection was concluded with few procedural observations


Remedium Lifecare to acquire manufacturing facility in Hyderabad
News | March 08, 2024

Remedium Lifecare to acquire manufacturing facility in Hyderabad

The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes


India approves Rs. 10,300 crore for AI Mission
Digitisation | March 08, 2024

India approves Rs. 10,300 crore for AI Mission

The investment will catalyse various components of the IndiaAI Mission


EMA validates MAAs for AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan in two types of cancer
Drug Approval | March 07, 2024

EMA validates MAAs for AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan in two types of cancer

The validations confirm the completion of the applications and commence the scientific review process


Bayer aims to enhance performance and regain strategic flexibility by 2026
News | March 06, 2024

Bayer aims to enhance performance and regain strategic flexibility by 2026

Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis